Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.840
-0.001 (-0.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gossamer Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 995.24% from the current stock price of 0.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 11, 2024.
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,090.48% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,090.48% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,090.48% | Aug 30, 2024 |
| Wedbush | Wedbush | Buy Reiterates $4 | Buy | Reiterates | $4 | +376.19% | Aug 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +971.43% | Jun 25, 2024 |
Financial Forecast
Revenue This Year
114.35M
Revenue Next Year
21.53M
from 114.35M
Decreased by -81.17%
EPS This Year
-0.29
from -1.18
EPS Next Year
-0.72
from -0.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 131.9M | 42.1M | 126.4M | |||
| Avg | 114.4M | 21.5M | 54.8M | |||
| Low | 103.2M | n/a | 16.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | -63.2% | 487.2% | |||
| Avg | - | -81.2% | 154.7% | |||
| Low | - | - | -24.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.19 | -0.55 | -0.19 | |||
| Avg | -0.29 | -0.72 | -0.48 | |||
| Low | -0.33 | -0.93 | -0.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.